<DOC>
	<DOC>NCT00137410</DOC>
	<brief_summary>This is a phase III, multicentre, randomized, double blind, parallel-group, pilot study designed to compare a long term (12 weeks) versus a short term (2 weeks) treatment with celecoxib 200 mg/die in treatment and prevention of new flare in patients with osteoarthritis of the knee.</brief_summary>
	<brief_title>Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>diagnosis of OA of the knee according to the ACR Classification Criteria for osteoarthritis; patients in flare any concomitant inflammatory rheumatic condition which may interfere with the assessment of OA clinical or radiological evidence of chondrocalcinosis</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>